Judges Scientific Interim Results H1 2024

Judges Scientific presented interim results for the six months ended 30 June 2024, highlighting its buy-and-build strategy in the scientific instrument market with 25 acquisitions since 2005 and strong organic revenue growth of 8% CAGR. The company demonstrated execution across three pillars of shareholder value creation: M&A, long-term drivers, and capital efficiency, with 28% CAGR total EBIT and 11% CAGR organic EBIT.